| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Jun 24, 2013Lorem ipsum dolor sit amet, consectetur adipiscing elit. Donec et risus odio. Vivamus pellentesque, tortor a tempor semper, massa nulla placerat augue, sit amet convallis tellus orci ut massa....
-
Jun 21, 2013
(Thomson Reuters ONE via COMTEX) --ASPIRE In-Home Study Published in New England Journal of Medicine and Presented at American Diabetes Association Annual Scientific Sessions CHICAGO - June 22,...
-
Jun 20, 2013
Thomson Reuters ONE via COMTEX) --MINNEAPOLIS - June 20, 2013 - The board of directors of Medtronic, Inc. (NYSE: MDT) today approved an 8 percent increase in its cash dividend, raising the...
-
Jun 20, 2013
Thomson Reuters ONE via COMTEX) --Shareholders Invited to Attend Annual Meeting on Aug. 22, 2013 MINNEAPOLIS - June 20, 2013 - The board of directors of Medtronic, Inc. (NYSE: MDT), today...
-
Jun 17, 2013
Thomson Reuters ONE via COMTEX) --INFUSE Bone Graft Remains Important Treatment Option MINNEAPOLIS - June 17, 2013 - Medtronic, Inc. [NYSE: MDT] acknowledged today the publication of the findings...
-
Jun 14, 2013
(Thomson Reuters ONE via COMTEX) --Study Presents Comprehensive Dataset of Patient Characteristics Collected on Extreme Risk TAVR Patients VANCOUVER - June 14, 2013 - Medtronic, Inc. (NYSE: MDT)...
-
Jun 13, 2013
Thomson Reuters ONE via COMTEX) --Novel Disruptive Instrument for Controlled and Progressive Restoration of the Sagittal Imbalance in Patient with Spinal Deformity NICE, France - June 13, 2013 -...
-
Jun 13, 2013
Thomson Reuters ONE via COMTEX) --MINNEAPOLIS - June 13, 2013 - Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the Wells Fargo...
-
Jun 5, 2013
(Thomson Reuters ONE via COMTEX) --MINNEAPOLIS - June 5, 2013 - Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the 34th Annual...
-
Jun 4, 2013
Thomson Reuters ONE via COMTEX) --Pacific Plus PTA Catheter Allows for Treatment of Myriad Arteries, from Renal and Iliac to Femoral and Popliteal MINNEAPOLIS -- June 4, 2013 -- Expanding its...
-
Jun 3, 2013
Thomson Reuters ONE via COMTEX) --Company Plans to Submit First Module of U.S. Approval Application for Novel Peripheral Angioplasty Device to FDA Over Summer MINNEAPOLIS -- June 3, 2013 --...
-
May 31, 2013
Thomson Reuters ONE via COMTEX) --Three-Year Clinical Data Presented at Annual Meeting of Society for Vascular Surgery Reaffirms Physician Confidence in Market-Leading Endovascular Device SAN...
-
May 30, 2013
(Thomson Reuters ONE via COMTEX) --Global Market-Leader in Medical Technology for Endovascular Aortic Repair Also Receives 510(k) Clearance for Sentrant Introducer Sheath MINNEAPOLIS -- May 30,...
-
May 24, 2013
Thomson Reuters ONE via COMTEX) --MINNEAPOLIS - May 24, 2013 - Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the Sanford...
-
May 23, 2013Presented at EuroPCR, One-Year Data from BELLO Study Show Durability of Clinical Results Following Treatment of De Novo Lesions with Novel Angioplasty Device
PARIS -- May 23, 2013 -- One-year data from an Italian multicenter randomized controlled trial of the IN.PACT Falcon drug-eluting balloon from Medtronic, Inc. (NYSE: MDT) demonstrate positive and...
-
May 23, 2013Replacing Degenerated Surgical Valves with CoreValve Results in Significant Hemodynamic Improvements for Patients
MINNEAPOLIS - May 23, 2013 - Medtronic, Inc. (NYSE: MDT) today announced it has received Conformité Européenne (CE) Mark for valve-in-valve (VIV) procedures using the CoreValve® and CoreValve®...
-
May 23, 2013Milestone Marks a Critical Step Forward in Bringing Renal Denervation to Patients in the U.S.
MINNEAPOLIS - May 23, 2013 - Medtronic, Inc. (NYSE: MDT), today announced it has finished randomizing Symplicity HTN-3, the company's pivotal U.S. clinical trial of the Symplicity(TM) renal...
-
May 21, 2013EuroPCR Presentation of "Real World" ADVANCE Study Confirms Economic Value of Novel Self-Expanding Valve in Patients Unable to Undergo Surgery
PARIS -- May 21, 2013 -- Focused on offering devices that provide both clinical and economic value, Medtronic, Inc. (NYSE: MDT) today unveiled the results of a cost-effectiveness model comparing...
-
May 21, 2013First Look at Data from Global SYMPLICITY Registry Shows Renal Denervation with the Symplicity(TM) System Meets Performance Expectations in Real-World Setting
MINNEAPOLIS and PARIS - MAY 21, 2013 - Medtronic, Inc. (NYSE: MDT), announced today the first results from the Global SYMPLICITY Registry, which reaffirmed the safety of the renal denervation...
-
May 21, 2013Initial Results from Feasibility Study of the Symplicity Spyral(TM) Catheter Show Safety and Efficacy While More than Halving Mean Procedure Time
MINNEAPOLIS and PARIS - MAY 21, 2013 - Medtronic, Inc. (NYSE: MDT) announced today preliminary results from the feasibility study of its Symplicity SpyralTM multi-electrode, 6 Fr renal denervation...
-
May 21, 2013EuroPCR Presentation of One-Year Data from Robust "Real World" Global Study Demonstrates One of the Lowest Mortality Rates among Similar TAVI Studies
PARIS -- May 21, 2013 -- Committed to generating robust clinical data on its CoreValve System for transcatheter aortic valve implantation (TAVI), Medtronic, Inc. (NYSE: MDT) today unveiled for the...
-
May 21, 2013Q4 Revenue of $4.5 Billion Grew 5% at Constant Currency; 4% as Reported
MINNEAPOLIS - May 21, 2013 - Medtronic, Inc. (NYSE: MDT) today announced financial results for its fourth quarter and fiscal year 2013, which ended April 26, 2013. The Company reported worldwide...
-
May 21, 2013Proven Lead Expands Access to MRI for Patients with Slow Heartbeat
TOLOCHENAZ - May 21, 2013 -- Medtronic today announced CE Mark (Conformité Européenne) and launch of its CapSureFix Novus(TM)5076 Lead, which is now approved in the EU for use in an MRI...
-
May 21, 2013Three Analyses Presented at EuroPCR Demonstrate Device's Durability in Addressing Common Clinical Challenge
PARIS -- May 22, 2013 -- Addressing one of the most common clinical challenges in the treatment of complex coronary artery disease, three separate analyses on the program for EuroPCR this week...
-
May 20, 2013Backed by Robust Clinical Data on Broad Product Family, New Thrombus Removal System Offers Superior Deliverability
MINNEAPOLIS -- May 20, 2013 -- Expanding its portfolio of medical technology for the interventional treatment of cardiovascular disease, Medtronic, Inc. (NYSE: MDT) announced today that the Export...